Related Experiment Video
Updated: Jul 15, 2025
09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
10.4K
Pediatric and Hereditary Mastocytosis
Joanna Renke1, Ninela Irga-Jaworska1, Magdalena Lange2
1Department of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, ul. Skłodowskiej-Curie 3A, 80-210 Gdańsk.
Immunology and Allergy Clinics of North America
|September 27, 2023
Summary
Pediatric mastocytosis presentation and treatment vary significantly with age. Early diagnosis in neonates may indicate severe disease, while older children may face long-term management challenges.
Area of Science:
- Pediatric Dermatology
- Hematology
- Allergy and Immunology
Background:
- Pediatric mastocytosis is a rare condition characterized by abnormal mast cell accumulation.
- Clinical manifestations and disease severity in pediatric mastocytosis are influenced by patient age.
Purpose of the Study:
- To summarize the age-dependent clinical spectrum of pediatric mastocytosis.
- To highlight treatment considerations and prognostic factors across different pediatric age groups.
Main Methods:
- Review of clinical presentations of pediatric mastocytosis.
- Analysis of age-specific disease characteristics and management strategies.
Main Results:
- Neonatal presentation often involves severe diffuse cutaneous mastocytosis requiring immediate intervention.
- Toddlers may necessitate long-term anti-mediator therapies and preparedness for anaphylaxis (e.g., epinephrine auto-injectors).
- Adolescents may experience persistent cutaneous disease or develop systemic mastocytosis.
Conclusions:
- Age at diagnosis is a critical determinant of the clinical picture and management of pediatric mastocytosis.
- Further research is essential to optimize age-specific treatment protocols and prognostic assessments for pediatric mastocytosis.
Related Concept Videos
01:20Inborn Errors of Metabolism
179
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
179
01:35Pedigree Analysis
84.4K
Overview
84.4K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K